General Public

This information sheet discusses treatment for latent TB infection. It reminds patients to keep their weekly medical visits, explains directly observed therapy, provides a list of items to discuss with their doctor, a medication schedule, and advises them to call the doctor immediately if they experience any of the side effects on the list. The information sheet also includes space for the doctor's and clinic's name and telephone number.

This information sheet discusses the once-a-week 12-week treatment of rifapentine and isoniazid for latent TB infection (LTBI). It explains LTBI, why it is necessary to treat it, the treatment plan and how it is managed, and a chart for tracking. It also includes hints on how to take the medicine including eating before taking it and avoiding alcohol, and describes normal side effects and possible problems including which signs and symptoms require you to call the doctor or nurse and what to do when taking a dose of medicine in the absence of medical staff.

This video was created by the WHO Global TB Programme for World TB Day 2019. This short video encourages viewers to participate in ending TB through testing, treatment, and information sharing.

This booklet provides information on the diagnosis and treatment of TB infection and TB disease. Key audiences for this resource are people with or at risk for TB; people who may have been exposed to someone with TB; people who provide services for those at high risk for TB, such as correctional officers, homeless shelter workers, and emergency responders; and people who want to learn more about tuberculosis.